Generic Videx EC approved for treatment of HIV

Mylan announced that the FDA has approved its Abbreviated New Drug Application (ANDA) for didanosine delayed-release capsules, the generic version of Videx EC (from Bristol Myers Squibb). Mylan’s didanosine delayed-release capsules are expected to be available this quarter in 125mg, 200mg, 250mg, and 400mg dosage strengths.

Didanosine delayed-release capsules are indicated for the treatment of HIV infection.

For more information call (800) Rx-MYLAN or visit www.mylan.com.